Cargando…

Dendritic Cells as Adjuvants for Immune-mediated Resistance to Tumors

Detalles Bibliográficos
Autores principales:	Schuler, G., Steinman, R.M.
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 1997
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2199101/ https://www.ncbi.nlm.nih.gov/pubmed/9379142

Ejemplares similares

Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity
por: Münz, Christian, et al.
Publicado: (2005)

Dendritic cell cross‐dressing and tumor immunity
por: Martinez‐Usatorre, Amaia, et al.
Publicado: (2022)

The Induction of Tolerance by Dendritic Cells That Have Captured Apoptotic Cells
por: Steinman, Ralph M., et al.
Publicado: (2000)

Will the Making of Plasmacytoid Dendritic Cells in Vitro Help Unravel Their Mysteries?
por: Banchereau, Jacques, et al.
Publicado: (2000)

Human dendritic cells. Enrichment and characterization from peripheral blood
por: Van Voorhis, WC, et al.
Publicado: (1982)

Trance, a Tumor Necrosis Factor Family Member, Enhances the Longevity and Adjuvant Properties of Dendritic Cells in Vivo
por: Josien, Régis, et al.
Publicado: (2000)

Adjuvants of Immunity : Harnessing Innate Immunity to Promote Adaptive Immunity
por: Bendelac, Albert, et al.
Publicado: (2002)

Absence of “Original Antigenic Sin” in Autoimmunity Provides an Unforeseen Platform for Immune Therapy
por: Steinman, Lawrence
Publicado: (1999)

Dendritic cells are the principal stimulators of the primary mixed leukocyte reaction in mice
por: Steinman, RM, et al.
Publicado: (1983)

Dendritic and Natural Killer Cells Cooperate in the Control/Switch of Innate Immunity
por: Zitvogel, Laurence
Publicado: (2002)

Waking immune-resistant tumors with neddylation
por: Huntoon, Kristin, et al.
Publicado: (2023)

Cross-presentation of glycolipid from tumor cells loaded with α-galactosylceramide leads to potent and long-lived T cell–mediated immunity via dendritic cells
por: Shimizu, Kanako, et al.
Publicado: (2007)

Dendritic cells mature to resist lamin degradation and herpes virus release
por: Niedergang, Florence
Publicado: (2019)

Studies of the cell surface of mouse dendritic cells and other leukocytes
por: Nussenzweig, MC, et al.
Publicado: (1981)

Human ES cell-derived dendritic cells: Meeting the challenge of immune rejection in allogeneic cell therapy
por: Zenke, Martin
Publicado: (2020)

Neisserial PorB immune enhancing activity and use as a vaccine adjuvant
por: Yuen, Rachel, et al.
Publicado: (2019)

Role of TOLL-like Receptors in Adjuvant-Augmented Immune Therapies by T. Seya
por: Cooper, Edwin L.
Publicado: (2006)

Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients
por: Boudewijns, Steve, et al.
Publicado: (2016)

Combined phospholipids adjuvant augments anti-tumor immune responses through activated tumor-associated dendritic cells
por: Shui, Yifang, et al.
Publicado: (2023)

Myelin-Specific Cd8 T Cells in the Pathogenesis of Experimental Allergic Encephalitis and Multiple Sclerosis
por: Steinman, Lawrence
Publicado: (2001)

Chemokines and the Homing of Dendritic Cells to the T Cell Areas of Lymphoid Organs
por: Cyster, Jason G.
Publicado: (1999)

Dendritic cells require a systemic type I interferon response to mature and induce CD4(+) Th1 immunity with poly IC as adjuvant
por: Longhi, M. Paula, et al.
Publicado: (2009)

Peptide-Pulsed Dendritic Cells Have Superior Ability to Induce Immune-Mediated Tissue Destruction Compared to Peptide with Adjuvant
por: Dissanayake, Dilan, et al.
Publicado: (2014)

Alarming dendritic cells for Th2 induction
por: MacDonald, Andrew S., et al.
Publicado: (2008)

Regulation of B Lymphocytes by Dendritic Cells
por: Clark, Edward A.
Publicado: (1997)

Differentiation of T Regulatory Cells by Immature Dendritic Cells
por: Roncarolo, Maria-Grazia, et al.
Publicado: (2001)

Antigen Presentation by Dendritic Cells In Vivo
por: Mougneau, Evelyne, et al.
Publicado: (2002)

Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion
por: DeVito, Nicholas C., et al.
Publicado: (2019)

Immune Tolerance After Delivery of Dying Cells to Dendritic Cells In Situ
por: Liu, Kang, et al.
Publicado: (2002)

Activation of Natural Killer T Cells by α-Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein
por: Fujii, Shin-ichiro, et al.
Publicado: (2003)

Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells
por: Liu, Kang, et al.
Publicado: (2005)

Mediating the death of dormant tumor cells
por: Liu, Yuying, et al.
Publicado: (2018)

Targeting Leishmania major Antigens to Dendritic Cells In Vivo Induces Protective Immunity
por: Matos, Ines, et al.
Publicado: (2013)

Immunologists getting nervous: neuropeptides, dendritic cells and T cell activation
por: Lambrecht, Bart N
Publicado: (2001)

Dendritic cell defects in patients with cancer: mechanisms and significance
por: Lenahan, Corrine, et al.
Publicado: (2006)

Mobilizing Dendritic Cells for Tolerance, Priming, and Chronic Inflammation
por: Sallusto, Federica, et al.
Publicado: (1999)

Fcγ Receptors and Cross-Presentation in Dendritic Cells
por: Amigorena, Sebastian
Publicado: (2002)

Pulmonary dendritic cells: thinking globally, acting locally
por: Randall, Troy D.
Publicado: (2010)

Dendritic cell-based in vitro assays for vaccine immunogenicity
por: Vandebriel, Rob J., et al.
Publicado: (2012)

The dendritic cell niche in chronic obstructive pulmonary disease
por: Haczku, Angela
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_1po0q5nh5pdjjpha5u1lt705or